WO2021019559A1 - Synthesis of 5-(3-pyridyl)-2,2'-bithiophene(sensitizer) - Google Patents
Synthesis of 5-(3-pyridyl)-2,2'-bithiophene(sensitizer) Download PDFInfo
- Publication number
- WO2021019559A1 WO2021019559A1 PCT/IN2020/050647 IN2020050647W WO2021019559A1 WO 2021019559 A1 WO2021019559 A1 WO 2021019559A1 IN 2020050647 W IN2020050647 W IN 2020050647W WO 2021019559 A1 WO2021019559 A1 WO 2021019559A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bithiophene
- pyridyl
- solvent
- reaction
- sensitizer
- Prior art date
Links
- POZYWSKVQJALAF-UHFFFAOYSA-N 3-(5-thiophen-2-ylthiophen-2-yl)pyridine Chemical compound C1=CSC(C=2SC(=CC=2)C=2C=NC=CC=2)=C1 POZYWSKVQJALAF-UHFFFAOYSA-N 0.000 title claims abstract description 16
- 230000015572 biosynthetic process Effects 0.000 title abstract description 13
- 238000003786 synthesis reaction Methods 0.000 title abstract description 10
- 238000000034 method Methods 0.000 claims abstract description 20
- OMOAIGVIYUXYAU-UHFFFAOYSA-N 2-bromo-5-thiophen-2-ylthiophene Chemical compound S1C(Br)=CC=C1C1=CC=CS1 OMOAIGVIYUXYAU-UHFFFAOYSA-N 0.000 claims description 27
- 238000006243 chemical reaction Methods 0.000 claims description 20
- 239000002904 solvent Substances 0.000 claims description 18
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 13
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Substances BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 claims description 11
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 claims description 11
- 150000001875 compounds Chemical class 0.000 claims description 10
- OHZAHWOAMVVGEL-UHFFFAOYSA-N 2,2'-bithiophene Chemical compound C1=CSC(C=2SC=CC=2)=C1 OHZAHWOAMVVGEL-UHFFFAOYSA-N 0.000 claims description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 8
- 239000007818 Grignard reagent Substances 0.000 claims description 7
- 239000003054 catalyst Substances 0.000 claims description 7
- 150000004795 grignard reagents Chemical class 0.000 claims description 7
- TUCRZHGAIRVWTI-UHFFFAOYSA-N 2-bromothiophene Chemical compound BrC1=CC=CS1 TUCRZHGAIRVWTI-UHFFFAOYSA-N 0.000 claims description 6
- ROIMNSWDOJCBFR-UHFFFAOYSA-N 2-iodothiophene Chemical compound IC1=CC=CS1 ROIMNSWDOJCBFR-UHFFFAOYSA-N 0.000 claims description 6
- KBVDUUXRXJTAJC-UHFFFAOYSA-N 2,5-dibromothiophene Chemical compound BrC1=CC=C(Br)S1 KBVDUUXRXJTAJC-UHFFFAOYSA-N 0.000 claims description 5
- NFHFRUOZVGFOOS-UHFFFAOYSA-N Pd(PPh3)4 Substances [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 claims description 5
- 239000002585 base Substances 0.000 claims description 5
- 229910052763 palladium Inorganic materials 0.000 claims description 5
- 235000011056 potassium acetate Nutrition 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 238000005580 one pot reaction Methods 0.000 claims description 4
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 claims description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
- 238000006069 Suzuki reaction reaction Methods 0.000 claims description 3
- 238000009815 homocoupling reaction Methods 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 150000001298 alcohols Chemical class 0.000 claims description 2
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 claims description 2
- 239000000010 aprotic solvent Substances 0.000 claims description 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 150000002170 ethers Chemical class 0.000 claims description 2
- 150000008282 halocarbons Chemical class 0.000 claims description 2
- 150000002576 ketones Chemical class 0.000 claims description 2
- 150000002825 nitriles Chemical class 0.000 claims description 2
- 239000003586 protic polar solvent Substances 0.000 claims description 2
- GGISZLOBBISXOZ-UHFFFAOYSA-N acetic acid;chloroform Chemical compound CC(O)=O.ClC(Cl)Cl GGISZLOBBISXOZ-UHFFFAOYSA-N 0.000 claims 1
- 239000003504 photosensitizing agent Substances 0.000 abstract description 6
- 239000000243 solution Substances 0.000 description 18
- 239000000203 mixture Substances 0.000 description 17
- 239000007787 solid Substances 0.000 description 17
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 14
- ABMYEXAYWZJVOV-UHFFFAOYSA-N pyridin-3-ylboronic acid Chemical compound OB(O)C1=CC=CN=C1 ABMYEXAYWZJVOV-UHFFFAOYSA-N 0.000 description 12
- 239000002002 slurry Substances 0.000 description 12
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 10
- XEMDFESAXKSEGI-UHFFFAOYSA-N 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine Chemical compound O1C(C)(C)C(C)(C)OB1C1=CC=CN=C1 XEMDFESAXKSEGI-UHFFFAOYSA-N 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- RYUKZEIKTHUIGL-UHFFFAOYSA-N O1BOBOB1C1=CC=CN=C1 Chemical compound O1BOBOB1C1=CC=CN=C1 RYUKZEIKTHUIGL-UHFFFAOYSA-N 0.000 description 8
- 239000007983 Tris buffer Substances 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 239000012044 organic layer Substances 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 5
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 5
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 5
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 238000006161 Suzuki-Miyaura coupling reaction Methods 0.000 description 4
- 238000006887 Ullmann reaction Methods 0.000 description 4
- 229960000583 acetic acid Drugs 0.000 description 4
- 238000003818 flash chromatography Methods 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- -1 phytosterol Chemical compound 0.000 description 4
- IVDFJHOHABJVEH-UHFFFAOYSA-N pinacol Chemical compound CC(C)(O)C(C)(C)O IVDFJHOHABJVEH-UHFFFAOYSA-N 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 235000005282 vitamin D3 Nutrition 0.000 description 4
- 239000011647 vitamin D3 Substances 0.000 description 4
- 229940021056 vitamin d3 Drugs 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 229960004132 diethyl ether Drugs 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- NYPYPOZNGOXYSU-UHFFFAOYSA-N 3-bromopyridine Chemical compound BrC1=CC=CN=C1 NYPYPOZNGOXYSU-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- 238000005577 Kumada cross-coupling reaction Methods 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- 239000007832 Na2SO4 Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 235000019439 ethyl acetate Nutrition 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 125000001072 heteroaryl group Chemical group 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- NHDIQVFFNDKAQU-UHFFFAOYSA-N tripropan-2-yl borate Chemical compound CC(C)OB(OC(C)C)OC(C)C NHDIQVFFNDKAQU-UHFFFAOYSA-N 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- BQPPJGMMIYJVBR-UHFFFAOYSA-N (10S)-3c-Acetoxy-4.4.10r.13c.14t-pentamethyl-17c-((R)-1.5-dimethyl-hexen-(4)-yl)-(5tH)-Delta8-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C BQPPJGMMIYJVBR-UHFFFAOYSA-N 0.000 description 1
- XQFJZHAVTPYDIQ-LETJEVNCSA-N (1s)-3-[(e)-2-[(1r,3ar,7ar)-1-[(e,2r,5r)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-1,2,3,3a,6,7-hexahydroinden-4-yl]ethenyl]-4-methylcyclohex-3-en-1-ol Chemical class C=1([C@@H]2CC[C@@H]([C@]2(CCC=1)C)[C@H](C)/C=C/[C@H](C)C(C)C)\C=C\C1=C(C)CC[C@H](O)C1 XQFJZHAVTPYDIQ-LETJEVNCSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- CHGIKSSZNBCNDW-UHFFFAOYSA-N (3beta,5alpha)-4,4-Dimethylcholesta-8,24-dien-3-ol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21 CHGIKSSZNBCNDW-UHFFFAOYSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- XYTLYKGXLMKYMV-UHFFFAOYSA-N 14alpha-methylzymosterol Natural products CC12CCC(O)CC1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C XYTLYKGXLMKYMV-UHFFFAOYSA-N 0.000 description 1
- WZOMHJNOGJDTPZ-UHFFFAOYSA-N 3-(4,6-dipyridin-3-yl-1,3,5,2,4,6-trioxatriborinan-2-yl)pyridine Chemical compound O1B(C=2C=NC=CC=2)OB(C=2C=NC=CC=2)OB1C1=CC=CN=C1 WZOMHJNOGJDTPZ-UHFFFAOYSA-N 0.000 description 1
- FPTJELQXIUUCEY-UHFFFAOYSA-N 3beta-Hydroxy-lanostan Natural products C1CC2C(C)(C)C(O)CCC2(C)C2C1C1(C)CCC(C(C)CCCC(C)C)C1(C)CC2 FPTJELQXIUUCEY-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 108010034984 D3 compound Proteins 0.000 description 1
- UCTLRSWJYQTBFZ-UHFFFAOYSA-N Dehydrocholesterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCCC(C)C)CCC33)C)C3=CC=C21 UCTLRSWJYQTBFZ-UHFFFAOYSA-N 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- BKLIAINBCQPSOV-UHFFFAOYSA-N Gluanol Natural products CC(C)CC=CC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(O)C(C)(C)C4CC3 BKLIAINBCQPSOV-UHFFFAOYSA-N 0.000 description 1
- LOPKHWOTGJIQLC-UHFFFAOYSA-N Lanosterol Natural products CC(CCC=C(C)C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 LOPKHWOTGJIQLC-UHFFFAOYSA-N 0.000 description 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 1
- CAHGCLMLTWQZNJ-UHFFFAOYSA-N Nerifoliol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C CAHGCLMLTWQZNJ-UHFFFAOYSA-N 0.000 description 1
- ZWKZBUNCVZNROQ-UHFFFAOYSA-N OC(C)(C)C(C)(C)O.N1=CC(=CC=C1)B(O)O Chemical compound OC(C)(C)C(C)(C)O.N1=CC(=CC=C1)B(O)O ZWKZBUNCVZNROQ-UHFFFAOYSA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- MJOQJPYNENPSSS-XQHKEYJVSA-N [(3r,4s,5r,6s)-4,5,6-triacetyloxyoxan-3-yl] acetate Chemical compound CC(=O)O[C@@H]1CO[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O MJOQJPYNENPSSS-XQHKEYJVSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000031709 bromination Effects 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000013058 crude material Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- QBSJHOGDIUQWTH-UHFFFAOYSA-N dihydrolanosterol Natural products CC(C)CCCC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 QBSJHOGDIUQWTH-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 229940052303 ethers for general anesthesia Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- CAHGCLMLTWQZNJ-RGEKOYMOSA-N lanosterol Chemical compound C([C@]12C)C[C@@H](O)C(C)(C)[C@H]1CCC1=C2CC[C@]2(C)[C@H]([C@H](CCC=C(C)C)C)CC[C@@]21C CAHGCLMLTWQZNJ-RGEKOYMOSA-N 0.000 description 1
- 229940058690 lanosterol Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- YUGCAAVRZWBXEQ-WHTXLNIXSA-N previtamin D3 Chemical class C=1([C@@H]2CC[C@@H]([C@]2(CCC=1)C)[C@H](C)CCCC(C)C)\C=C/C1=C(C)CC[C@H](O)C1 YUGCAAVRZWBXEQ-WHTXLNIXSA-N 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 238000010583 slow cooling Methods 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000003577 thiophenes Chemical class 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Definitions
- the present invention relates to a novel, simple and short process for synthesis of the photosensitizer, 5-(3-pyridyl)-2,2'-bithiophene.
- Vitamin D3 is commercially produced from its precursors such as 7- dehydrocholesterol and other isomers such as cholesterol, phytosterol, ergosterol, lanosterol by irradiation at suitable wavelengths.
- the irradiation processes has certain disadvantages such as it results in the formation of undesired isomers/ impurities and requires additional purification leading to escalation in costs.
- the final vitamin D3 compound obtained should be produced free from detrimental contaminants. It is therefore essential that the photochemical conversion preferably yields a single well-defined product with the desired properties. Insufficient conversion and/or the formation of by-products during the conversion reaction produce(s) contaminated end product which is often tedious, sometimes even impossible, to purify such reaction products up to a purity suitable for human or veterinary use.
- Photosensitizers are nowadays used in the irradiation process for production of vitamin D3 since they block certain wavelengths and aid in obtaining the desired end product with minimum or no contamination.
- US5252191 discloses substituted thiophene derivatives of general formula (I) having a substantial absorption in the wavelength region of approx. 300-1,000 nm as improved photosensitizer over the art during photochemical conversion of tachysterol compounds into previtamin D compounds and of trans vitamin D compounds into cis-vitamin D compounds.
- One such photosensitizer encompassed in the general Markush structure of Formula (I) in US’ 191 is 5-(3-pyridyl)-2,2’-bithiophene.
- the said sensitizer can be easily removed from the reaction mixture after the irradiation is complete.
- the present invention provides a simple, short process for preparation of sensitizer 5-(3-pyridyl)-2,2’-bithiophene comprising;
- step (ii) Brominating intermediate (1) of step (i) to obtain 5-bromo-2,2’- bithiophene (2); followed by iii. Suzuki coupling of compound (2) of step (ii) with compound of formula (4)
- R 1 and R 2 are hydrogen; or with tris- 3-pyridyl boroxine or with a compound of formula (4) wherein R 1 and R 2 when taken together represent the group;
- the compound 5-bromo-2, 2' -bithiophene (2) may alternately be prepared in one pot comprising converting 2-bromothiophene to Grignard reagent followed by reaction with a solution of 2,5-dibromothiophene.
- the present invention relates to a simple, short process for preparation of sensitizer 5-(3-pyridyl)-2,2’-bithiophene comprising;
- step (ii) Brominating intermediate (1) of step (i) to obtain 5-bromo-2,2’- bithiophene (2); followed by iii. Suzuki coupling of compound (2) of step (ii) with compound of
- R 1 and R 2 are hydrogen; or with tris 3-pyridyl boroxine or with a compound of formula (4) wherein R 1 and R 2 when taken together represent the group;
- the present invention provides an improved Ullmann reaction for coupling of 2- iodothiophene to obtain 2,2’bithiophene (1).
- Ullmann reaction is carried out using copper or its complexes as catalyst.
- these copper- mediated transformations are usually conducted under harsh conditions (neat, >200°C) besides the requirement of a stoichiometric amount of Cu catalyst.
- the present invention discloses the use of palladium catalyst for Ullmann reaction and the reaction proceeds to completion at lower temperature range of 90-100°C to yield biaryl compound.
- Ullmann reaction is performed in presence of weak base such as potassium acetate which reduces the formation of undesired side products and improves the yield.
- the present invention further successfully employs selective nuclear mono brominating agent N-bromosuccinimide in chloroform-gl. acetic acid.
- NBS nuclear mono brominating agent
- the bromination step of the present invention does not require the additional use of radical initiators or the use of UV lamp to initiate the reaction and the reaction proceeds smoothly to yield the desired product in good yield and purity.
- N-bromosuccinimide as brominating agent in mixture of glacial acetic acid and chloroform and the mixture was stirred at room temperature. The mixture was then poured into ice-water and extracted in solvent, washed, dried and purified by column chromatography to obtain 5-bromo-2,2’- bithiophene (2).
- the process for preparing tris 3- pyridylboroxin comprises adding drop wise solution of n-butyl lithium to 3-neck flask charged with solvent cooled below -60°C. After the internal temperature reached to -60°C a solution of 3-bromopyridine was added drop wise to keep the internal temperature below -50°C. A brownish-black solid was precipitated and the resultant slurry was stirred for another 10-30 minutes. The solvent was added drop- wise to keep the internal temperature below -50°C and the resultant slurry was stirred for another 10 to 20 min. To the slurry was added triisopropyl borate in one portion via syringe.
- the solution was warmed to about -15°C, quenched with acid transferred to a separatory funnel.
- the aqueous layer was collected and the organic layer was washed severally with water.
- the aqueous layer was neutralized to pH 7 and extracted in solvent.
- the combined organic layer were concentrated and the residue was dissolved in solvent mixture, filtered, diluted, distilled the solvent, concentrated to afford 3-pyridineboronic acid (1).
- the 3- pyridineboronic acid (1) was taken up in the solvent for crystallization.
- the resulting slurry was heated to 60- 75°C for about an hour and allowed to cool slowly to RT and then cooled to 0°C.
- the present invention provides a process for preparation of 3-Pyridylboronic acid pinacol ester (3). Accordingly, 3- pyridylboroxin (2) as prepared above was refluxed with pinacol in the solvent using Dean -Stark apparatus for about 2-4h until the cloudy white reaction mixture became clear.
- the present invention provides a one pot process for preparation of the compound 5-bromo-2, 2' -bithiophene (2) comprising converting 2-bromothiophene to Grignard reagent followed by reaction with a solution of 2,5-dibromothiophene which is then converted to 5-(3-pyridyl)-2,2'-bithiophene as shown in Scheme 3.
- 2-bromothiophene was added to a slurry of magnesium turnings in anhydrous THF at reflux temperature. After completion of reaction, the Grignard reagent was filtered to remove the excess of magnesium, and the resulting solution was kept under a blanket of argon prior to use. In the Kumada coupling reaction, the Grignard reagent added in a period of about 15 min to a solution of 2,5-dibromothiophene at room temperature. Catalyst was added and the mixture was stirred at room temperature until maximum completion of starting material. Reaction was quenched in aqu.
- the solvents for the process is selected from polar or non-polar; protic or aprotic solvent such as lower alcohols, ethers, esters, ketones, nitriles, aliphatic or aromatic hydrocarbons, halogenated hydrocarbons and the like in suitable amount.
- the base for the reaction is selected from organic or inorganic base and includes but is not limited to ethylamine, pyridine, alkali metal carbonate or bicarbonate and the like in suitable amount.
- N-Bromosuccinimide (NBS, 9.6 g, 0.054mol) was added in small portions to a stirred solution of 2,2'-bithiophene (7.4g, 0.045mol) in 100 ml of glacial acetic acid and 100 ml of chloroform. After stirring for 1 h at room temperature, the mixture was poured into ice-water and extracted into chloroform (500 ml). The organic layer was washed with aqueous sodium bicarbonate solution, water, and then dried over magnesium sulfate and evaporated. The residue was subjected to flash chromatography on silica gel using hexane to give light green solid.
- 2-bromothiophene (10. Og, 0.06 mol) was added in 1 h to a slurry of 1.3 equiv of magnesium tumings(1.9g, 0.078mol) in anhydrous THF (50 mL). Addition was carried out at reflux temperature. After addition of all 2-bromothiophene the mixture was kept at reflux temperature during 1 h. The stirrer was stopped, the Grignard reagent was filtered to remove the excess of magnesium, and the resulting solution was kept under a blanket of argon prior to use.
- tris 3-pyridylboroxin the pyridine-3 -boronic acid solid obtained above was dissolved in THF/CH3OH (1: 1, 140 mL), filtered and diluted to 300 mL with CH3CN. The solvent was switched to CH3CN by distillation and concentrated to 100 mL. The resulting slurry was heated to 70°C for lh and allowed to cool slowly to RT before it was cooled to 0°C for 30 min. The solids were collected by filtration, washed the solid cake with cold acetonitrile, dried under vacuum to afford tris 3-pyridylboroxin as an off white solid which could also be used as such for further Suzuki-Miyaura cross coupling reactions.
- the mixture was stirred at 70-80°C for 16 hrs and then cooled to ambient temperature.
- the mixture was poured into dichloromethane (500 mL); washed sequentially with NaHCO 3 (sat.) (75 mL) and NaCl(sat) (150 mL); dried over Na 2 SO 4 ; filtered; and concentrated.
- the crude material was purified by silica gel chromatography (eluting with 3: 1 hexanes :EtOAc) to give 5-(3-pyridyl)-2,2'-bithiophene as pale yellow solid.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Disclosed herein is a novel simple, short process for synthesis of the photosensitizer, 5-(3-pyridyl)-2,2'-bithiophene.
Description
SYNTHESIS OF 5-(3-PYRIDYL)-2,2'-BITHIOPHENE (Sensitizer)
TECHNICAL FIELD OF INVENTION:
The present invention relates to a novel, simple and short process for synthesis of the photosensitizer, 5-(3-pyridyl)-2,2'-bithiophene.
BACKGROUND OF THE INVENTION:
Vitamin D3 is commercially produced from its precursors such as 7- dehydrocholesterol and other isomers such as cholesterol, phytosterol, ergosterol, lanosterol by irradiation at suitable wavelengths. The irradiation processes has certain disadvantages such as it results in the formation of undesired isomers/ impurities and requires additional purification leading to escalation in costs.
With the intended use of vitamin D3, viz. for human or veterinary administration, the final vitamin D3 compound obtained should be produced free from detrimental contaminants. It is therefore essential that the photochemical conversion preferably yields a single well-defined product with the desired properties. Insufficient conversion and/or the formation of by-products during the conversion reaction produce(s) contaminated end product which is often tedious, sometimes even impossible, to purify such reaction products up to a purity suitable for human or veterinary use.
Photosensitizers are nowadays used in the irradiation process for production of vitamin D3 since they block certain wavelengths and aid in obtaining the desired end product with minimum or no contamination.
US5252191 discloses substituted thiophene derivatives of general formula (I) having a substantial absorption in the wavelength region of approx. 300-1,000 nm as improved photosensitizer over the art during photochemical conversion of tachysterol compounds into previtamin D compounds and of trans vitamin D compounds into cis-vitamin D compounds.
(variables are as defined in US’ 191)
One such photosensitizer encompassed in the general Markush structure of Formula (I) in US’ 191 is 5-(3-pyridyl)-2,2’-bithiophene.
The said sensitizer can be easily removed from the reaction mixture after the irradiation is complete.
In light of the advantageous feature of the said photosensitizer, 5-(3-pyridyl)-2,2’- bithiophene, the present inventors felt that there is a scope to provide a more simple, cost effective process for synthesis of 5-(3-pyridyl)-2,2’-bithiophene over the process disclosed in US5252191.
SUMMARY OF THE INVENTION:
In line with the above, the present invention provides a simple, short process for preparation of sensitizer 5-(3-pyridyl)-2,2’-bithiophene comprising;
i. Homo coupling of 2-iodothiophene under palladium catalysed Ullmann condition in presence of potassium acetate and acetone to obtain 2,2’bithiophene (1);
ii. Brominating intermediate (1) of step (i) to obtain 5-bromo-2,2’- bithiophene (2); followed by
iii. Suzuki coupling of compound (2) of step (ii) with compound of formula (4)
when R1 and R2 are hydrogen; or with tris- 3-pyridyl boroxine or with a compound of formula (4) wherein R1 and R2 when taken together represent the group;
In an aspect, the compound 5-bromo-2, 2' -bithiophene (2) may alternately be prepared in one pot comprising converting 2-bromothiophene to Grignard reagent followed by reaction with a solution of 2,5-dibromothiophene.
DETAILED DESCRIPTION OF THE INVENTION:
The invention will now be described in detail in connection with certain preferred and optional embodiments, so that various aspects thereof may be more fully understood and appreciated.
In an embodiment, the present invention relates to a simple, short process for preparation of sensitizer 5-(3-pyridyl)-2,2’-bithiophene comprising;
i. Homo coupling of 2-iodothiophene under palladium catalyzed Ullmann condition in presence of potassium acetate and acetone to obtain 2,2’bithiophene (1);
ii. Brominating intermediate (1) of step (i) to obtain 5-bromo-2,2’- bithiophene (2); followed by
iii. Suzuki coupling of compound (2) of step (ii) with compound of
when R1 and R2 are hydrogen; or with tris 3-pyridyl boroxine or with a compound of formula (4) wherein R1 and R2 when taken together represent the group;
The process is depicted in Scheme 1:
The present invention provides an improved Ullmann reaction for coupling of 2- iodothiophene to obtain 2,2’bithiophene (1). Typically, Ullmann reaction is carried out using copper or its complexes as catalyst. However, these copper- mediated transformations are usually conducted under harsh conditions (neat, >200°C) besides the requirement of a stoichiometric amount of Cu catalyst. To avoid the harsh conditions, the present invention discloses the use of palladium catalyst for Ullmann reaction and the reaction proceeds to completion at lower temperature range of 90-100°C to yield biaryl compound. Further, in the present invention Ullmann reaction is performed in presence of weak base such as potassium acetate which reduces the formation of undesired side products and improves the yield.
The present invention further successfully employs selective nuclear mono brominating agent N-bromosuccinimide in chloroform-gl. acetic acid. By optimizing the equivalents of NBS in chloroform-gl. acetic acid the reaction can be performed at room temperature which results in high yield of monobrominated intermediate (2). The bromination step of the present invention does not require the additional use of radical initiators or the use of UV lamp to initiate the reaction and the reaction proceeds smoothly to yield the desired product in good yield and purity.
Accordingly, mixture of 2-iodothiophene, palladium tetraacetate, potassium acetate were stirred in the solvent at a temperature ranging from 90-110°C until completion of the reaction as monitored by TLC and GC analysis. The mixture was filtered, washed with organic solvent and the organic layers were evaporated under vacuum, purified to obtain purified 2,2’bithiophene (1).
To the above solid (1) was added N-bromosuccinimide as brominating agent in mixture of glacial acetic acid and chloroform and the mixture was stirred at room temperature. The mixture was then poured into ice-water and extracted in solvent,
washed, dried and purified by column chromatography to obtain 5-bromo-2,2’- bithiophene (2).
To the degassed aq. solution of sodium carbonate was added tris 3-pyridylboroxin (obtained from 3-pyridineboronic acid) or 3-Pyridylboronic Acid Pinacol Ester, 5-bromo-2,2'-bithiophene obtained above, catalyst Pd(PPh3)4 and the mixture was stirred at 70-80°C for about 14-17 hours. The mixture was then cooled to ambient temperature and poured in to solvent, washed sequentially, dried, filtered concentrated and purified to yield 5-(3-pyridyl)-2,2'-bithiophene as pale yellow solid.
In an embodiment of the present process, the process for preparing tris 3- pyridylboroxin comprises adding drop wise solution of n-butyl lithium to 3-neck flask charged with solvent cooled below -60°C. After the internal temperature reached to -60°C a solution of 3-bromopyridine was added drop wise to keep the internal temperature below -50°C. A brownish-black solid was precipitated and the resultant slurry was stirred for another 10-30 minutes. The solvent was added drop- wise to keep the internal temperature below -50°C and the resultant slurry was stirred for another 10 to 20 min. To the slurry was added triisopropyl borate in one portion via syringe. The solution was warmed to about -15°C, quenched with acid transferred to a separatory funnel. The aqueous layer was collected and the organic layer was washed severally with water. The aqueous layer was neutralized to pH 7 and extracted in solvent. The combined organic layer were concentrated and the residue was dissolved in solvent mixture, filtered, diluted, distilled the solvent, concentrated to afford 3-pyridineboronic acid (1). The 3- pyridineboronic acid (1) was taken up in the solvent for crystallization. The resulting slurry was heated to 60- 75°C for about an hour and allowed to cool slowly to RT and then cooled to 0°C. The solid obtained was filtered, washed, dried under vacuum to afford tris 3-pyridylboroxin (2) for further use in Suzuki- Miyaura cross coupling reaction with aryl/hetero aryl halides.
In yet another embodiment, the present invention provides a process for preparation of 3-Pyridylboronic acid pinacol ester (3). Accordingly, 3- pyridylboroxin (2) as prepared above was refluxed with pinacol in the solvent using Dean -Stark apparatus for about 2-4h until the cloudy white reaction mixture became clear. The solution was then concentrated to provide solid which was crystallized in the solvent by heating at 80-85°C for about half an hour followed by slow cooling to RT, filtering and drying to afford 3-Pyridylboronic acid pinacol ester (3) for further use in Suzuki- Miyaura cross coupling reaction with aryl/hetero aryl halides.
The process for preparing 3-pyridylboroxin (2) and 3-Pyridylboronic acid pinacol ester (3) is depicted in Scheme 2 below:
Scheme 2:
In the alternate embodiment, the present invention provides a one pot process for preparation of the compound 5-bromo-2, 2' -bithiophene (2) comprising converting 2-bromothiophene to Grignard reagent followed by reaction with a solution of
2,5-dibromothiophene which is then converted to 5-(3-pyridyl)-2,2'-bithiophene as shown in Scheme 3.
Scheme 3:
Accordingly, 2-bromothiophene was added to a slurry of magnesium turnings in anhydrous THF at reflux temperature. After completion of reaction, the Grignard reagent was filtered to remove the excess of magnesium, and the resulting solution was kept under a blanket of argon prior to use. In the Kumada coupling reaction, the Grignard reagent added in a period of about 15 min to a solution of 2,5-dibromothiophene at room temperature. Catalyst was added and the mixture was stirred at room temperature until maximum completion of starting material. Reaction was quenched in aqu. ammonium chloride, extracted in solvent, dried and purified to yield 5-bromo-2, 2' -bithiophene (2) which was further converted to 5-(3-pyridyl)-2,2'-bithiophene by the process stated above.
The solvents for the process is selected from polar or non-polar; protic or aprotic solvent such as lower alcohols, ethers, esters, ketones, nitriles, aliphatic or
aromatic hydrocarbons, halogenated hydrocarbons and the like in suitable amount.
The base for the reaction is selected from organic or inorganic base and includes but is not limited to ethylamine, pyridine, alkali metal carbonate or bicarbonate and the like in suitable amount.
EXAMPLES:
Example 1: Synthesis of 2,2’-Bithiophene
A mixture of 2-iodothiophene (10g, 0. 047 mol), Pd(OAc)2 (10mol %), and KOAc (2.3g 0.24mol, 5 equiv) was stirred in acetone (100 mL) at 100°C until complete consumption of starting material as monitored by TLC and GC analysis. Then the mixture was filtered with a crude flash column chromatography and washed with diethyl ether. The organic layers were evaporated under vacuum, the residue was purified by flash column chromatography (hexane, or hexane/ethyl acetate) to afford the pure product. The colorless liquid solidifies on cooling and turns to dark brown with time.
Yield : 7.4g
Purity: 96%
1H NMR (300 MHz): 7.22-7.19 (m, 4H), 7.04-7.00 (m, 2H); 13C NMR (75 MHz): 137.4, 127.8, 124.3, 123.8.
Example 2: Synthesis of 5-bromo-2,2'-bithiophene:
N-Bromosuccinimide (NBS, 9.6 g, 0.054mol) was added in small portions to a stirred solution of 2,2'-bithiophene (7.4g, 0.045mol) in 100 ml of glacial acetic acid and 100 ml of chloroform. After stirring for 1 h at room temperature, the mixture was poured into ice-water and extracted into chloroform (500 ml). The organic layer was washed with aqueous sodium bicarbonate solution, water, and then dried over magnesium sulfate and evaporated. The residue was subjected to flash chromatography on silica gel using hexane to give light green solid.
Yield: 9.5 g (88%)
M.pt. 55-56°C
Example 2a: Alternate one pot synthesis of 5-bromo-2,2’-bithiophene:
2-bromothiophene, (10. Og, 0.06 mol) was added in 1 h to a slurry of 1.3 equiv of magnesium tumings(1.9g, 0.078mol) in anhydrous THF (50 mL). Addition was carried out at reflux temperature. After addition of all 2-bromothiophene the mixture was kept at reflux temperature during 1 h. The stirrer was stopped, the Grignard reagent was filtered to remove the excess of magnesium, and the resulting solution was kept under a blanket of argon prior to use.
In the Kumada coupling reaction, to a solution of 2,5-dibromothiophene (0.06 mol, 14.5 g) in diethylether (50 mL) at room temperature was added the catalyst, Pd(dppf)C12 (0.15 mmol, 60 mg). Grignard reagent (50 mL,1.4 M) was then added in 15 min to the mixture and the reaction mixture was stirred at room temperature until maximum completion of starting material. Reaction was quenched by adding aqueous NH4CI and extracted with diethyl ether, dried over anhydrous Na2SO4 and solvent removed to get crude mass which upon purification by flash chromatography on silica gel using heptane gave 5-bromo-2,2’-bithiophene as light green solid.
Yield: 8.0g(55%)
M.pt: 54-56°C
Example 3: Synthesis of tris 3-pyridylboroxin
To a 500mL 3-necked flask was charged toluene (85 mL), cooled to below -60°C and a solution of n-BuLi (1.6 M in hexane, 48.6 mL, 77.8 mmol) was added drop wise over 10 min. After the internal temperature reached -60°C a solution of 3- bromopyridine (6.8 mL, 70.7 m mol) in toluene (30 mL) was added drop wise to keep the internal temperature below -50°C. A brownish-black solid precipitated and the resultant slurry was stirred for 20 min. THF (30 mL) was added drop-wise to keep the internal temperature below -50°C and the resultant slurry was stirred for 15min. To the slurry was added triisopropyl borate (19.6 mL, 84.9 mmol) in one portion via syringe. The solution was warmed to -15°C, quenched with HC1
(aq) (2.7 N, 70.0 mL) and transferred to a separatory funnel. The aqueous layer was collected and the organic layer was washed with water (10 mL), the combined aqueous layers were neutralized to pH 7 with NaOH(aq) (10 N) and extracted with THF (200 mL x 1, 125 mL x 2). The combined organics were concentrated in vacuo to get pyridine-3-boronic acid as buff coloured solid.
To prepare tris 3-pyridylboroxin, the pyridine-3 -boronic acid solid obtained above was dissolved in THF/CH3OH (1: 1, 140 mL), filtered and diluted to 300 mL with CH3CN. The solvent was switched to CH3CN by distillation and concentrated to 100 mL. The resulting slurry was heated to 70°C for lh and allowed to cool slowly to RT before it was cooled to 0°C for 30 min. The solids were collected by filtration, washed the solid cake with cold acetonitrile, dried under vacuum to afford tris 3-pyridylboroxin as an off white solid which could also be used as such for further Suzuki-Miyaura cross coupling reactions.
Yield: 6.4g (73%)
1H NMR (CD3OD) 8.64 (br s, IH), 8.50 (m, IH), 8.38 (br s, IH), 7.65 (br s, IH).
Example 4: Synthesis of 3-(4,4,5,5-Tetramethyl-[l,3,2]dioxaborolan-2- yl)pyridine (3-Pyridyl boronic Acid Pinacol Ester )
500-mL, one-necked, round-bottomed flask equipped with a magnetic stirbar and a Dean- Stark trap fitted with a condenser capped with a nitrogen inlet adaptor is charged with tris(3-pyridyl)boroxin (6.0 g, 18.2 mmol), pinacol (8.14 g, 68.8 mmol ) and 200 mL of toluene. The solution was heated at reflux for 3.0 h in a 120 °C oil bath. The reaction was complete when the mixture changes from cloudy-white to clear. The solution was concentrated under reduced pressure on a rotary evaporator to afford a solid residue. The solid was suspended in 15 mL of cyclohexane and the slurry was heated to 85°C, stirred at this temperature for 30 min, and then allowed to cool slowly to room temperature. The slurry was filtered, washed with cyclohexane, and dried under vacuum to afford 3-pyridylboronic acid pinacol ester as a white solid which could be used for further for Suzuki- Miyaura cross coupling reactions
Yield: 9.0 g
M.Pt: 103-106°C
Example 5: Synthesis of 5-(3-pyridyl)-2,2'-bithiophene
Only degassed solvents were used under air-free conditions. A degassed 2M aqueous solution of sodium carbonate (75 mL) was added to a mixture of 3- pyridineboronic acid(5.28g , 0.043 moles) of example 3 or 3-pyridineboronic acid pinacol ester(8.8g, 0.043 moles) of example 4, 5-bromo-2,2'-bithiophene (9.5g, 0.039moles), and 1, 1'-bis(diphenyl phosphino) ferrocene]-dichloro palladium or tetrakis (triphenylphosphine)palladium (2.25 g, 5mol%) in DMF (250 mL). The mixture was stirred at 70-80°C for 16 hrs and then cooled to ambient temperature. The mixture was poured into dichloromethane (500 mL); washed sequentially with NaHCO3(sat.) (75 mL) and NaCl(sat) (150 mL); dried over Na2SO4; filtered; and concentrated. The crude material was purified by silica gel chromatography (eluting with 3: 1 hexanes :EtOAc) to give 5-(3-pyridyl)-2,2'-bithiophene as pale yellow solid.
Yield: 7.5 g (72%)
HPLC purity: >95%
Claims
1. A simple, short process for preparation of sensitizer 5-(3-pyridyl)-2,2’- bithiophene comprising;
i. Homo coupling of 2-iodothiophene under palladium catalysed Ullmann condition in presence of potassium acetate and acetone to obtain 2,2’bithiophene (1);
ii. Brominating intermediate (1) of step (i) with NBS in gl. acetic acid - chloroform to obtain 5-bromo-2, 2' -bithiophene (2); followed by iii. Suzuki coupling of intermediate (2) of step (ii) with compound of formula (4)
when R1 and R2 are hydrogen; or with tris- 3-pyridyl boroxine or with a compound of formula (4) wherein R1 and R2 when taken together represent the group;
2. The simple, short process as claimed in claim 1, wherein the process step (i) is carried out at temperature ranging from 90-110°C.
3. The simple, short process as claimed in claim 1, wherein the intermediate 5-bromo-2,2’-bithiophene (2) is optionally prepared in one pot by a process comprising converting 2-bromothiophene to Grignard reagent followed by reaction with a solution of 2,5-dibromothiophene in presence of Pd(dppf)C12catalyst.
4. The simple, short process as claimed in claims 1 to 3, wherein the solvent is selected from polar, non-polar; aprotic or protic solvent such as lower alcohols, ethers, esters, ketones, nitriles, aliphatic or aromatic hydrocarbons, halogenated hydrocarbons and the like.
5. Sensitizer 5-(3-pyridyl)-2,2’-bithiophene prepared by the process as claimed in claims 1 to 4.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN201921030775 | 2019-07-30 | ||
IN201921030775 | 2019-07-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2021019559A1 true WO2021019559A1 (en) | 2021-02-04 |
Family
ID=74229834
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2020/050647 WO2021019559A1 (en) | 2019-07-30 | 2020-07-27 | Synthesis of 5-(3-pyridyl)-2,2'-bithiophene(sensitizer) |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2021019559A1 (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5252191A (en) * | 1990-04-27 | 1993-10-12 | Duphar International Research B.V. | Method for the photochemical isomerization of organic compounds under the influence of a photosensitizer |
-
2020
- 2020-07-27 WO PCT/IN2020/050647 patent/WO2021019559A1/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5252191A (en) * | 1990-04-27 | 1993-10-12 | Duphar International Research B.V. | Method for the photochemical isomerization of organic compounds under the influence of a photosensitizer |
Non-Patent Citations (2)
Title |
---|
ISABELLE KONDOLFF, DOUCET HENRI, SANTELLI MAURICE: "Suzuki Coupling Reactions of Heteroarylboronic Acids with Aryl Halides and Arylboronic Acids with Heteroaryl Bromides Using a Tetraphosphine/Palladium Catalyst", SYNLETT, vol. 13, 12 July 2005 (2005-07-12), pages 2057 - 2061, XP055788751, DOI: 10.1055/s-2005-871951 * |
YI-AN CHEN AND LIU CHING-YUAN: "Convenient synthesis of organic-electronicsoriented building blocks via on-water and under-air homocoupling of (hetero)aryl iodides", RSC ADVANCES, vol. 5, no. 91, 25 August 2015 (2015-08-25), pages 74180 - 74188, XP055788744, DOI: 10.1039/C5RA13517F * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2044076B1 (en) | Process for the preparation of asenapine and intermediate products used in said process. | |
CA2863467C (en) | Process for the preparation of phenyl substituted 3-difluoromethyl-1-methyl-1h-pyrazole-4-carboxylic acid n-methoxy- [1-methyl-2-phenylethyl] amides | |
JP6731990B2 (en) | Processes and intermediates for preparing α,ω-dicarboxylic acid terminated dialkane ethers | |
JP6147856B2 (en) | Processes and intermediates for preparing integrase inhibitors | |
CN111471047A (en) | Method for the selective synthesis of pyrazolo[1,2-a]pyrazolones or 2-acylindole compounds | |
CN113603568A (en) | Preparation method of cannabidiol | |
CN112778173A (en) | Synthesis method of silver (I) trifluoromethanesulfonate | |
CN110698467A (en) | Synthetic method of engagliflozin | |
JP5965499B2 (en) | Halogenated aniline and process for producing the same | |
CN102757390B (en) | Method for preparing 2-methoxy-4-diazanyl-5-fluoropyrimidine | |
CN102558069B (en) | Method for preparing intermediate in process of preparing bendamustine hydrochloride | |
WO2021019559A1 (en) | Synthesis of 5-(3-pyridyl)-2,2'-bithiophene(sensitizer) | |
CN109232222B (en) | A kind of preparation method of (E)-oct-4-ene-1,8-dioic acid | |
CN107814757B (en) | Method for synthesizing polysubstituted pyrrole derivative | |
CN111662147B (en) | Process for preparing diynes and analogues thereof | |
CN102030690B (en) | A kind of ligand with axial chiral double sulfoxide and its synthetic method | |
JP4588989B2 (en) | Process for producing 5-formyl-2-furylboric acid | |
CN110590641B (en) | A kind of green preparation method of 3-hydroxyisoindol-1-one series compounds | |
KR20090085173A (en) | Novel alkylaryl selenide derivatives and preparation methods thereof | |
JP4902247B2 (en) | Novel production method of 2- (1-benzothiophen-5-yl) ethanol and its intermediate | |
WO2021019558A1 (en) | An efficient method for synthesis of 5-(3-pyridyl)-2,2'-bithiophene(sensitizer) | |
CN119390654A (en) | A method for preparing polysubstituted imidazole derivatives | |
JP2706554B2 (en) | 4-trifluoromethylaniline derivative and method for producing the same | |
Wang et al. | The synthesis and application of fluorous boronates without perfluorinated solvents | |
CN115260074A (en) | Preparation method of Paxlovid intermediate of oral antiviral drug |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 20848613 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 20848613 Country of ref document: EP Kind code of ref document: A1 |